Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ragnarsson

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|February 19, 1998
Review article: Targeted drug delivery in treatment of intestinal diseasesM Wikberg, J Ulmius, G Ragnarsson
European Journal of Clinical Pharmacology|January 1, 1988
Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CRA Sandberg, G Ragnarsson, U E Jonsson, et al.
International Journal of Oncology|May 5, 2011
Loss of heterozygosity at chromosome 1p in human breast cancerG Ragnarsson, A Sigurdsson, G Eiriksdottir, et al.
British Journal of Cancer|April 3, 1999
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survivalG Ragnarsson, G Eiriksdottir, J T Johannsdottir, et al.
Journal of Medical Genetics|May 12, 2000
Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancerB I Sigbjörnsdottir, G Ragnarsson, B A Agnarsson, et al.
Pharmeuropa Bio & Scientific Notes|December 15, 2010
Quality control of metoprolol extended-release formulations in the presence of ethanolA Amini, A Dawood, A-M Hesselgren, et al.
Anticancer Research|September 2, 1999
Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variablesJ T Johannsdottir, J T Bergthorsson, S Gretarsdottir, et al.
Anticancer Research|January 1, 1997
Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variablesA K Kristjansson, G Eiriksdottir, G Ragnarsson, et al.
Scandinavian Journal of Gastroenterology|March 10, 2017
The incidence and outcome of ischemic colitis in a population-based settingY Yngvadottir, B R Karlsdottir, J P Hreinsson, et al.
Cancer Research|October 10, 1998
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationS Ingvarsson, E K Geirsdottir, G Johannesdottir, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|February 19, 1998
Review article: Targeted drug delivery in treatment of intestinal diseasesM Wikberg, J Ulmius, G Ragnarsson
European Journal of Clinical Pharmacology|January 1, 1988
Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CRA Sandberg, G Ragnarsson, U E Jonsson, et al.
International Journal of Oncology|May 5, 2011
Loss of heterozygosity at chromosome 1p in human breast cancerG Ragnarsson, A Sigurdsson, G Eiriksdottir, et al.
British Journal of Cancer|April 3, 1999
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survivalG Ragnarsson, G Eiriksdottir, J T Johannsdottir, et al.
Journal of Medical Genetics|May 12, 2000
Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancerB I Sigbjörnsdottir, G Ragnarsson, B A Agnarsson, et al.
Pharmeuropa Bio & Scientific Notes|December 15, 2010
Quality control of metoprolol extended-release formulations in the presence of ethanolA Amini, A Dawood, A-M Hesselgren, et al.
Anticancer Research|September 2, 1999
Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variablesJ T Johannsdottir, J T Bergthorsson, S Gretarsdottir, et al.
Anticancer Research|January 1, 1997
Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variablesA K Kristjansson, G Eiriksdottir, G Ragnarsson, et al.
Scandinavian Journal of Gastroenterology|March 10, 2017
The incidence and outcome of ischemic colitis in a population-based settingY Yngvadottir, B R Karlsdottir, J P Hreinsson, et al.
Cancer Research|October 10, 1998
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationS Ingvarsson, E K Geirsdottir, G Johannesdottir, et al.
Pageof 3